NCT01268566 - A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions

Glioblastoma Multiforme

Interventions

DRUG

MEDI-575

MEDI-575 as an IV infusion.

Trial Locations (12)

Research Site, Tucson

Research Site, Los Angeles

Research Site, Stanford

Research Site, Chicago

Research Site, Boston

Research Site, Detroit

Research Site, New York

Research Site, Canton

Research Site, Pittsburgh

Research Site, Nashville

Research Site, San Antonio

Research Site, Seattle